| abstract |
The present invention relates to a composition comprising at least one mimotope of an epitope of α-synuclein for use in a method for preventing and / or treating synucleinopathies, wherein said at least one mimotope is a non-toxic diphtheria toxin Binds to a pharmaceutically acceptable carrier protein selected from the group consisting of a mutant, keyhole limpet hemocyanin (KLH), diphtheria toxin (DT), tetanus toxoid (TT), and Haemophilus influenzae protein D (protein D) Or, the composition is fused. |